중대질병보험 시장 : 용도별(암, 심장 발작, 뇌졸중, 기타), 보험료 형태별(월차, 분기, 반기, 연차), 최종 사용자별(개인, 기업) - 세계 기회 분석 및 산업 예측(2021-2031년)

The critical illness insurance cover provides the insured with financial security against various life-threatening health conditions such as kidney failures, cardiovascular diseases, and cancer. Critical illness insurance cover includes a lump sum payment in case the insured is diagnosed with a listed illness.

Rise in number of health issues due to unhealthy lifestyle of people causes serious illness such as kidney failures, heart attack, cancer and other such serious illness have increased the demand for critical illness insurance coverage among consumers. In addition, rise in awareness about the benefits of a critical illness insurance coverage among consumers is a major driving factor for the market. Moreover, the cost of treatment without having an insurance coverage may lead to huge medical bills for which customers opt for the critical illness insurance. These are some of the factors propelling the growth of the critical illness insurance market. However, high amount of premium for the critical illness insurance is a major factor limiting the growth of the market. On the contrary, smooth experience offered by the insurance coverage pertaining to reimbursement of medical bills and cashless treatments at best hospitals without the worry of high fees charged for operation and treatments is expected to provide lucrative growth opportunities in the coming years.

The critical illness insurance market is segmented on the basis of application, premium mode, end user, and region. By application, it is classified into cancer, heart attack, stroke, and others. By premium mode, it is categorized into monthly, quarterly, half yearly, and yearly. By application, it is bifurcated into individual, and businesses. The businesses segment is further sub segmented into group policies and individual policies. The group policies segment is further divided into simplified issue policies, and fully underwritten policies. By region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The report analyzes the profiles of key players operating in the critical illness insurance market such as Aegon, AFLAC INCORPORATED, Allianz Care, American International Group, Inc., Aviva, AXA Hong Kong, Bajaj Allianz General Insurance Co. Ltd., Cigna, Future Generali India Insurance Company Ltd., Legal & General Group plc, Liberty Mutual Insurance, MetLife Services and Solutions, LLC., Royal London, Sun Life Assurance Company of Canada, United HealthCare Services, Inc., Modern Insurance Agency, Inc., and Plum Benefits Private Limited. These players have adopted various strategies to increase their market penetration and strengthen their position in the critical illness insurance industry.

Key Benefits For Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the critical illness insurance market analysis from 2021 to 2031 to identify the prevailing critical illness insurance market opportunities.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the critical illness insurance market segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global critical illness insurance market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Application

• Others
• Cancer
• Heart Attack
• Stroke

By Premium Mode

• Monthly
• Quarterly
• Half Yearly
• Yearly

By End User

• Individual
• Businesses

By Region

• North America
  • U.S.
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Rest Of Europe
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Singapore
  • Rest Of Asia-Pacific
• LAMEA
  • Latin America
  • Middle East
  • Africa
• Key Market Players
  • Aegon
  • AFLAC INCORPORATED
  • Allianz Care
  • American International Group, Inc.
  • Aviva
  • AXA
  • Bajaj Allianz General Insurance Co. Ltd.
  • Cigna
  • Future Generali India Insurance Company Ltd.
  • Legal & General Group plc
  • Liberty Mutual Insurance
  • MetLife Services and Solutions, LLC.
  • Royal London
  • Sun Life Assurance Company of Canada
  • United HealthCare Services, Inc.
  • Modern Insurance Agency, Inc.
  • Plum Benefits Private Limited

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

• 1.1.Report description
• 1.2.Key market segments
• 1.3.Key benefits to the stakeholders
• 1.4.Research Methodology
  • 1.4.1.Secondary research
  • 1.4.2.Primary research
  • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

• 2.1.Key findings of the study
• 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

• 3.1.Market definition and scope
• 3.2.Key findings
  • 3.2.1.Top investment pockets
• 3.3.Porter's five forces analysis
• 3.4.Top player positioning
• 3.5.Market dynamics
  • 3.5.1.Drivers
  • 3.5.2.Restraints
  • 3.5.3.Opportunities
• 3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: CRITICAL ILLNESS INSURANCE MARKET, BY APPLICATION

• 4.1 Overview
  • 4.1.1 Market size and forecast
• 4.2 Cancer
  • 4.2.1 Key market trends, growth factors and opportunities
  • 4.2.2 Market size and forecast, by region
  • 4.2.3 Market analysis by country
• 4.3 Heart Attack
  • 4.3.1 Key market trends, growth factors and opportunities
  • 4.3.2 Market size and forecast, by region
  • 4.3.3 Market analysis by country
• 4.4 Stroke
  • 4.4.1 Key market trends, growth factors and opportunities
  • 4.4.2 Market size and forecast, by region
  • 4.4.3 Market analysis by country
• 4.5 Others
  • 4.5.1 Key market trends, growth factors and opportunities
  • 4.5.2 Market size and forecast, by region
  • 4.5.3 Market analysis by country

CHAPTER 5: CRITICAL ILLNESS INSURANCE MARKET, BY PREMIUM MODE

• 5.1 Overview
  • 5.1.1 Market size and forecast
• 5.2 Monthly
  • 5.2.1 Key market trends, growth factors and opportunities
  • 5.2.2 Market size and forecast, by region
  • 5.2.3 Market analysis by country
• 5.3 Quarterly
  • 5.3.1 Key market trends, growth factors and opportunities
  • 5.3.2 Market size and forecast, by region
  • 5.3.3 Market analysis by country
• 5.4 Half Yearly
  • 5.4.1 Key market trends, growth factors and opportunities
  • 5.4.2 Market size and forecast, by region
  • 5.4.3 Market analysis by country
• 5.5 Yearly
  • 5.5.1 Key market trends, growth factors and opportunities
  • 5.5.2 Market size and forecast, by region
  • 5.5.3 Market analysis by country

CHAPTER 6: CRITICAL ILLNESS INSURANCE MARKET, BY END USER

• 6.1 Overview
  • 6.1.1 Market size and forecast
• 6.2 Individual
  • 6.2.1 Key market trends, growth factors and opportunities
  • 6.2.2 Market size and forecast, by region
  • 6.2.3 Market analysis by country
• 6.3 Businesses
  • 6.3.1 Key market trends, growth factors and opportunities
  • 6.3.2 Market size and forecast, by region
  • 6.3.3 Market analysis by country

CHAPTER 7: CRITICAL ILLNESS INSURANCE MARKET, BY REGION

• 7.1 Overview
  • 7.1.1 Market size and forecast
• 7.2 North America
  • 7.2.1 Key trends and opportunities
  • 7.2.2 North America Market size and forecast, by Application
  • 7.2.3 North America Market size and forecast, by Premium Mode
  • 7.2.4 North America Market size and forecast, by End User
  • 7.2.5 North America Market size and forecast, by country
    • 7.2.5.1 U.S.
    • 7.2.5.1.1 Market size and forecast, by Application
    • 7.2.5.1.2 Market size and forecast, by Premium Mode
    • 7.2.5.1.3 Market size and forecast, by End User
    • 7.2.5.2 Canada
    • 7.2.5.2.1 Market size and forecast, by Application
    • 7.2.5.2.2 Market size and forecast, by Premium Mode
    • 7.2.5.2.3 Market size and forecast, by End User
• 7.3 Europe
  • 7.3.1 Key trends and opportunities
  • 7.3.2 Europe Market size and forecast, by Application
  • 7.3.3 Europe Market size and forecast, by Premium Mode
  • 7.3.4 Europe Market size and forecast, by End User
  • 7.3.5 Europe Market size and forecast, by country
    • 7.3.5.1 UK
    • 7.3.5.1.1 Market size and forecast, by Application
    • 7.3.5.1.2 Market size and forecast, by Premium Mode
    • 7.3.5.1.3 Market size and forecast, by End User
    • 7.3.5.2 Germany
    • 7.3.5.2.1 Market size and forecast, by Application
    • 7.3.5.2.2 Market size and forecast, by Premium Mode
    • 7.3.5.2.3 Market size and forecast, by End User
    • 7.3.5.3 France
    • 7.3.5.3.1 Market size and forecast, by Application
    • 7.3.5.3.2 Market size and forecast, by Premium Mode
    • 7.3.5.3.3 Market size and forecast, by End User
    • 7.3.5.4 Italy
    • 7.3.5.4.1 Market size and forecast, by Application
    • 7.3.5.4.2 Market size and forecast, by Premium Mode
    • 7.3.5.4.3 Market size and forecast, by End User
    • 7.3.5.5 Spain
    • 7.3.5.5.1 Market size and forecast, by Application
    • 7.3.5.5.2 Market size and forecast, by Premium Mode
    • 7.3.5.5.3 Market size and forecast, by End User
    • 7.3.5.6 Netherlands
    • 7.3.5.6.1 Market size and forecast, by Application
    • 7.3.5.6.2 Market size and forecast, by Premium Mode
    • 7.3.5.6.3 Market size and forecast, by End User
    • 7.3.5.7 Rest of Europe
    • 7.3.5.7.1 Market size and forecast, by Application
    • 7.3.5.7.2 Market size and forecast, by Premium Mode
    • 7.3.5.7.3 Market size and forecast, by End User
• 7.4 Asia-Pacific
  • 7.4.1 Key trends and opportunities
  • 7.4.2 Asia-Pacific Market size and forecast, by Application
  • 7.4.3 Asia-Pacific Market size and forecast, by Premium Mode
  • 7.4.4 Asia-Pacific Market size and forecast, by End User
  • 7.4.5 Asia-Pacific Market size and forecast, by country
    • 7.4.5.1 China
    • 7.4.5.1.1 Market size and forecast, by Application
    • 7.4.5.1.2 Market size and forecast, by Premium Mode
    • 7.4.5.1.3 Market size and forecast, by End User
    • 7.4.5.2 India
    • 7.4.5.2.1 Market size and forecast, by Application
    • 7.4.5.2.2 Market size and forecast, by Premium Mode
    • 7.4.5.2.3 Market size and forecast, by End User
    • 7.4.5.3 Japan
    • 7.4.5.3.1 Market size and forecast, by Application
    • 7.4.5.3.2 Market size and forecast, by Premium Mode
    • 7.4.5.3.3 Market size and forecast, by End User
    • 7.4.5.4 Australia
    • 7.4.5.4.1 Market size and forecast, by Application
    • 7.4.5.4.2 Market size and forecast, by Premium Mode
    • 7.4.5.4.3 Market size and forecast, by End User
    • 7.4.5.5 Singapore
    • 7.4.5.5.1 Market size and forecast, by Application
    • 7.4.5.5.2 Market size and forecast, by Premium Mode
    • 7.4.5.5.3 Market size and forecast, by End User
    • 7.4.5.6 Rest of Asia-Pacific
    • 7.4.5.6.1 Market size and forecast, by Application
    • 7.4.5.6.2 Market size and forecast, by Premium Mode
    • 7.4.5.6.3 Market size and forecast, by End User
• 7.5 LAMEA
  • 7.5.1 Key trends and opportunities
  • 7.5.2 LAMEA Market size and forecast, by Application
  • 7.5.3 LAMEA Market size and forecast, by Premium Mode
  • 7.5.4 LAMEA Market size and forecast, by End User
  • 7.5.5 LAMEA Market size and forecast, by country
    • 7.5.5.1 Latin America
    • 7.5.5.1.1 Market size and forecast, by Application
    • 7.5.5.1.2 Market size and forecast, by Premium Mode
    • 7.5.5.1.3 Market size and forecast, by End User
    • 7.5.5.2 Middle East
    • 7.5.5.2.1 Market size and forecast, by Application
    • 7.5.5.2.2 Market size and forecast, by Premium Mode
    • 7.5.5.2.3 Market size and forecast, by End User
    • 7.5.5.3 Africa
    • 7.5.5.3.1 Market size and forecast, by Application
    • 7.5.5.3.2 Market size and forecast, by Premium Mode
    • 7.5.5.3.3 Market size and forecast, by End User

CHAPTER 8: COMPANY LANDSCAPE

• 8.1. Introduction
• 8.2. Top winning strategies
• 8.3. Product Mapping of Top 10 Player
• 8.4. Competitive Dashboard
• 8.5. Competitive Heatmap
• 8.6. Key developments

CHAPTER 9: COMPANY PROFILES

• 9.1 Aegon
  • 9.1.1 Company overview
  • 9.1.2 Company snapshot
  • 9.1.3 Operating business segments
  • 9.1.4 Product portfolio
  • 9.1.5 Business performance
  • 9.1.6 Key strategic moves and developments
• 9.2 AFLAC INCORPORATED
  • 9.2.1 Company overview
  • 9.2.2 Company snapshot
  • 9.2.3 Operating business segments
  • 9.2.4 Product portfolio
  • 9.2.5 Business performance
  • 9.2.6 Key strategic moves and developments
• 9.3 Allianz Care
  • 9.3.1 Company overview
  • 9.3.2 Company snapshot
  • 9.3.3 Operating business segments
  • 9.3.4 Product portfolio
  • 9.3.5 Business performance
  • 9.3.6 Key strategic moves and developments
• 9.4 American International Group, Inc.
  • 9.4.1 Company overview
  • 9.4.2 Company snapshot
  • 9.4.3 Operating business segments
  • 9.4.4 Product portfolio
  • 9.4.5 Business performance
  • 9.4.6 Key strategic moves and developments
• 9.5 Aviva
  • 9.5.1 Company overview
  • 9.5.2 Company snapshot
  • 9.5.3 Operating business segments
  • 9.5.4 Product portfolio
  • 9.5.5 Business performance
  • 9.5.6 Key strategic moves and developments
• 9.6 AXA
  • 9.6.1 Company overview
  • 9.6.2 Company snapshot
  • 9.6.3 Operating business segments
  • 9.6.4 Product portfolio
  • 9.6.5 Business performance
  • 9.6.6 Key strategic moves and developments
• 9.7 Bajaj Allianz General Insurance Co. Ltd.
  • 9.7.1 Company overview
  • 9.7.2 Company snapshot
  • 9.7.3 Operating business segments
  • 9.7.4 Product portfolio
  • 9.7.5 Business performance
  • 9.7.6 Key strategic moves and developments
• 9.8 Cigna
  • 9.8.1 Company overview
  • 9.8.2 Company snapshot
  • 9.8.3 Operating business segments
  • 9.8.4 Product portfolio
  • 9.8.5 Business performance
  • 9.8.6 Key strategic moves and developments
• 9.9 Future Generali India Insurance Company Ltd.
  • 9.9.1 Company overview
  • 9.9.2 Company snapshot
  • 9.9.3 Operating business segments
  • 9.9.4 Product portfolio
  • 9.9.5 Business performance
  • 9.9.6 Key strategic moves and developments
• 9.10 Legal & General Group plc
  • 9.10.1 Company overview
  • 9.10.2 Company snapshot
  • 9.10.3 Operating business segments
  • 9.10.4 Product portfolio
  • 9.10.5 Business performance
  • 9.10.6 Key strategic moves and developments
• 9.11 Liberty Mutual Insurance
  • 9.11.1 Company overview
  • 9.11.2 Company snapshot
  • 9.11.3 Operating business segments
  • 9.11.4 Product portfolio
  • 9.11.5 Business performance
  • 9.11.6 Key strategic moves and developments
• 9.12 MetLife Services and Solutions, LLC.
  • 9.12.1 Company overview
  • 9.12.2 Company snapshot
  • 9.12.3 Operating business segments
  • 9.12.4 Product portfolio
  • 9.12.5 Business performance
  • 9.12.6 Key strategic moves and developments
• 9.13 Royal London
  • 9.13.1 Company overview
  • 9.13.2 Company snapshot
  • 9.13.3 Operating business segments
  • 9.13.4 Product portfolio
  • 9.13.5 Business performance
  • 9.13.6 Key strategic moves and developments
• 9.14 Sun Life Assurance Company of Canada
  • 9.14.1 Company overview
  • 9.14.2 Company snapshot
  • 9.14.3 Operating business segments
  • 9.14.4 Product portfolio
  • 9.14.5 Business performance
  • 9.14.6 Key strategic moves and developments
• 9.15 United HealthCare Services, Inc.
  • 9.15.1 Company overview
  • 9.15.2 Company snapshot
  • 9.15.3 Operating business segments
  • 9.15.4 Product portfolio
  • 9.15.5 Business performance
  • 9.15.6 Key strategic moves and developments
• 9.16 Modern Insurance Agency, Inc.
  • 9.16.1 Company overview
  • 9.16.2 Company snapshot
  • 9.16.3 Operating business segments
  • 9.16.4 Product portfolio
  • 9.16.5 Business performance
  • 9.16.6 Key strategic moves and developments
• 9.17 Plum Benefits Private Limited
  • 9.17.1 Company overview
  • 9.17.2 Company snapshot
  • 9.17.3 Operating business segments
  • 9.17.4 Product portfolio
  • 9.17.5 Business performance
  • 9.17.6 Key strategic moves and developments